Quintana LB

Language: Spanish
References: 27
Page: 511-518
PDF size: 89.94 Kb.

ABSTRACT

Life expectancy has been significantly increased worldwide. This phenomenon has caused changes in disease patterns, with a high prevalence of chronic pain in over 65 years old patients, specifically non-oncological pain. The challenges imposed for their treatment are not avoidable and potential success lays in the knowledge of the peculiarities of the elderly and the drugs used to treat pain. All these can be achieved if professionals know the major physiological changes and pathological conditions associated with aging, as well as the pharmacology of opioids, an interaction that is more important for these purposes than prescription itself, as the changes caused by aging and the diseases present in each patient in particular may affect all processes in the intraorganic cycle of drugs. All of these factors should be taken into consideration at the beginning and during the treatment. This work approaches to recommendations for the therapeutic approach of opioids, not getting deep in the individuality of each product considering that there is no evidence of the use of all them the elderly. Therefore, only those for which there is evidence are addressed.

REFERENCES

1. Organización Mundial de la Salud. Mejores cuidados paliativos para personas mayores. Ginebra: OMS; 2004.

2. Romero Cabrera J. La fragilidad como punto de corte en geriatría. Geriátrika. 2006;22(2):42-6.

3. Álamo C. Opioides y dolor crónico en el paciente geriátrico. Del reto al éxito. Rev Soc Esp Dolor. 2008;15(7):437- 9.

4. Romero Cabrera AJ, Espinosa Roca A, Fresneda Quintana O, Misas Menéndez M. Atención hospitalaria al paciente con enfermedad terminal. Finlay. 2005;10(Esp):144-7.

5. Espinosa SE, Fried LP. Risk factors for frailty in the older adult. Clinical Geriatrics. 2007;15(6):37-44.

6. Kitahara M, Kojima KK, Ohmura A. Efficacy of interdisciplinary treatment for chronic nonmalignant pain patients in Japan. Clin J Pain. 2006;22(7):647-55.

7. Salazar R. Opioides en el adulto mayor. Bogotá: ACED; 2009.

8. Mencias AB, Rodríguez JL. Consideraciones sobre el empleo de opioides en el dolor crónico del paciente geriátrico. Rev Soc Esp Dolor. 2008;15(7):463-74.

9. Carceller Ruíz J. Opioides en el anciano. Galicia: Sociedad Española del Dolor; 2006.

10. Pergolizzi J, Boger R, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III Opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8(4):287-313.

11. Lynch ME, Watson PN. The pharmacotherapy of chronic pain: A review. Pain Res Manage. 2006;11(1):11-38.

12. Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, et al. Drugs in palliative care: results from a representative survey in Germany. Palliat Med. 2004;18(2):100-7.

13. Jost L, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(Suppl 5):v257 -60.

14. Sullivan MD, Gaster B, Russo J, Bowlby L, Rocco N, Sinex N, et al. Randomized trial of we-based training about opioid therapy for chronic pain. Clin J Pain. 2010;26(6):512-7.

15. Hakonsen GD, Strelec P, Campbell D, Hudson S, Loennechen T. Adherence to medication guideline criteria in cancer pain management. J Pain Symptom Manage. 2009;37(6):1006-18.

16. Furlan A, Reardon R, Weppler C. Opioids for chronic non cancer pain: a new Canadian practice guideline. CMJA. 2010;182(9):923-30.

17. Wilder-Smith OH. Opioid use in the elderly. Eur J Pain. 2005;9(2):137-40.

18. Gutstein H, Akil H. Analgésicos opioides. En: Hardman JG, Limbird LE, eds. Goodman Gilman. Las bases farmacológicas de la terapéutica. México, DF: Mc Graw Hill; 2003. p. 577-628.

19. Cátedra extraordinaria del dolor. Fundación Grunenthal. Manejo de opioides en el dolor osteoarticular. Salamanca: Universidad de Salamanca; 2003.

20. Fonzo-Christe C, Vukasovic C, Wasilewski-Rasca AF, Bonnabry P. Subcutaneous administration of drugs in the elderly. Palliat Med. 2005;19(3):208-19.

21. Sittl R. Transdermal buprenorphine in cancer pain and palliative care. Palliat Med. 2006;20:25-30.

22. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain. 2005;9(2):127-30.

23. Gómez Carracedo A, Baztán Cortés JJ. Métodos de evaluación de la función renal en el paciente anciano: fiabilidad e implicaciones clínicas. Rev Esp Geriatr Gerontol. 2009;44(5):266-72.

24. Heras M, Guerrero MT, Fernández Reyes MJ, Sánchez R, Muñoz A, Macías MC, et al. Las manifestaciones analíticas asociadas a la insuficiencia renal crónica: ¿a partir de qué grado de filtrado glomerular estimado las detectamos en ancianos?. Rev Esp Geriatr Gerontol. 2009;44(3):143-5.

25. Delgado Silveira E, Muñoz García M, Montero Errasquin B, Sánchez Castellano C, Gallagher PF, Cruz-Jentoft AJ. Prescripción inapropiada de medicamentos en los pacientes mayores: los criterios STOPP/START. Rev Esp Geriatr Gerontol. 2009;44(5):273-9.

26. Plancarte Sánchez R, Gutiérrez Velásquez H. Buprenorfina transdérmica en pacientes con dolor oncológico. Cancerología. 2006;1:253-71.

27. Heretogh CM. Advance care planning and the relevance of a palliative care approach in dementia. Age Ageing. 2006;35(6):553–5.